Le Lézard
Classified in: Health, Science and technology
Subjects: Conference, Webcast

Viridian Therapeutics to Participate in Upcoming May Investor Conferences


Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biopharmaceutical company focused on discovering and developing potential best-in-class medicines for serious and rare diseases, today announced that senior management will participate in the following upcoming investor conferences in May:

A live webcast of each presentation can be accessed under "Events and Presentations" on the Investors section of the Viridian website at viridiantherapeutics.com. A replay of the webcasts will be available following the completion of the event.

About Viridian Therapeutics

Viridian is a biopharmaceutical company focused on engineering and developing potential best-in-class medicines for patients with serious and rare diseases. Viridian's expertise in antibody discovery and protein engineering enables the development of differentiated therapeutic candidates for previously validated drug targets in commercially established disease areas.

Viridian is advancing multiple candidates in the clinic for the treatment of patients with thyroid eye disease (TED). The company is conducting a pivotal program for VRDN-001, including two global phase 3 clinical trials (THRIVE and THRIVE-2) to evaluate its efficacy and safety in patients with active and chronic TED. Viridian's goal is to advance VRDN-001 as a potential best-in-class intravenous therapy followed by VRDN-003 as a potential best-in-class subcutaneous therapy for the treatment of TED.

In addition to its TED portfolio, Viridian is advancing a novel portfolio of neonatal Fc receptor (FcRn) inhibitors, including VRDN-006 and VRDN-008, which has the potential to be developed in multiple autoimmune diseases.

Viridian is based in Waltham, Massachusetts. For more information, please visit www.viridiantherapeutics.com. Follow Viridian on LinkedIn and X.


These press releases may also interest you

at 15:29
AGCO Corporation, , a global leader in the design, manufacture and distribution of agricultural machinery and precision ag technology, announced today that it will participate in the 2024 J.P. Morgan Global Technology, Media and Communications...

at 15:26
"We call it Xtraspots (pronounced as extra spots), aiming to release the usage rights of parking spaces," explains Charles Sepulveda Co-Founder and President. Unlike other competitors who focus on partnering with parking lots, Xtraspots targets...

at 15:15
A star-studded and powerful room of women's health advocates, experts, and leaders came together at Hearst Tower in New York City on May 15 for the inaugural Women's Health Health Lab in partnership with the Northwell Health's Katz Institute for...

at 14:52
RWI Logistics, a leading cold chain-oriented logistics solutions provider, today announced a strategic engagement with Metafora, a renowned technology and business consulting firm focused exclusively on the transportation and logistics industry. This...

at 14:40
Verint® , The CX Automation Companytm, today announced that a leading consumer financial services firm is achieving strong artificial intelligence (AI) business outcomes with Verint Intelligent Virtual Assistant (IVA). The firm reports experiencing...

at 14:38
Otto Ladder Safety, Inc. (the parent company of Otto Tech Systems) announced the election of H.P. Goldfield, Cory Scott, and James Bifulco to its Board of Directors....



News published on and distributed by: